Recurrent Lung Carcinoma (DBCOND0055774)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - ABSK-091
- Adavosertib
- Afatinib
- Binimetinib
- Capivasertib
- Copanlisib
- Crizotinib
- Dabrafenib
- Dasatinib
- Defactinib
- Erdafitinib
- GSK-2636771
- Ipatasertib
- Larotrectinib
- Methane
- Nivolumab
- Osimertinib
- Palbociclib
- Pertuzumab
- Relatlimab
- Sapanisertib
- Sulfate ion
- Sunitinib
- Taselisib
- Trametinib
- Trastuzumab
- Trastuzumab emtansine
- Tyrosine
- Ulixertinib
- Vismodegib
screening 2 active_not_recruiting NCT01638533 Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction treatment 1 active_not_recruiting NCT02318771 Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer treatment 1 completed NCT04267913 Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial) treatment 2 withdrawn NCT01522820 Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors treatment 1 completed NCT04662645 Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers No drug interventions supportive_care Not Available completed